Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Shares Outstanding (2020 - 2025)

Rapid Micro Biosystems' Shares Outstanding history spans 4 years, with the latest figure at $5.3 billion for Q2 2023.

  • For Q2 2023, Shares Outstanding fell 4.39% year-over-year to $5.3 billion; the TTM value through Jun 2023 reached $5.3 billion, down 4.39%, while the annual FY2022 figure was $5.6 million, 99.92% down from the prior year.
  • Shares Outstanding for Q2 2023 was $5.3 billion at Rapid Micro Biosystems, down from $36.8 billion in the prior quarter.
  • Across five years, Shares Outstanding topped out at $36.8 billion in Q1 2023 and bottomed at $353465.0 in Q2 2020.
  • The 4-year median for Shares Outstanding is $5.4 billion (2022), against an average of $11.0 billion.
  • The largest YoY upside for Shares Outstanding was 574595.36% in 2022 against a maximum downside of 19.56% in 2022.
  • A 4-year view of Shares Outstanding shows it stood at $358465.0 in 2020, then soared by 1925716.75% to $6.9 billion in 2021, then dropped by 19.56% to $5.6 billion in 2022, then fell by 4.39% to $5.3 billion in 2023.
  • Per Business Quant, the three most recent readings for RPID's Shares Outstanding are $5.3 billion (Q2 2023), $36.8 billion (Q1 2023), and $5.6 billion (Q4 2022).